KLRS
#3953
Kalaris Therapeutics, Inc. - Common Stock
4.5 1 USD
-0.01%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-0.88%
Changement Mensuel
+2.50%
Evolution sur 6 mois
-55.91%
Changement Annuel
-55.91%
Clôture Précédente
4.5 5
Open
4.5 1
Low
4.5 1
High
4.5 1
Volume
1
Financials
- Market Capitalization 107.3 M
- Employee 20
- Founded 2019
- CEO N/A
- Website www.kalaristx.com
- Headquarter Delaware, United States
- FIGI BBG00P80SH34
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3929 |  COYA Coya Therapeutics, Inc. - Common Stock | 4.85 USD | -0.41% | -9.85% | -1.22% | -21.65% | 113.77 M USD | ||
| 3944 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.90 USD | -1.10% | +8.43% | +2.27% | -21.05% | 107.42 M USD | ||
| 3959 |  BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.84 USD | -1.08% | -3.16% | +6.36% | -37.63% | 105.44 M USD | ||
| 3972 |  ICCC ImmuCell Corporation - Common Stock | 11.17 USD | -4.69% | +6.69% | +17.33% | +76.18% | 101.05 M USD |